Valuation: Sartorius Stedim Biotech

Market Cap 17.06B 19.39B 15.84B 14.57B 27.33B 1,878B 27.82B 189B 73.9B 916B 72.8B 71.23B 3,178B P/E 2026 *
44.6x
P/E 2027 * 35x
Enterprise Value 19.4B 22.05B 18.02B 16.57B 31.08B 2,136B 31.64B 215B 84.04B 1,042B 82.79B 81B 3,614B EV / Sales 2026 *
6.13x
EV / Sales 2027 * 5.39x
Free-Float
28.47%
Yield 2026 *
0.49%
Yield 2027 * 0.59%
1 day-6.45%
1 week-12.49%
Current month-9.69%
1 month+0.49%
3 months+3.86%
6 months-20.39%
Current year-21.90%
1 week 158.9
Extreme 158.9
189.2
1 month 158.9
Extreme 158.9
190.8
Current year 150
Extreme 150
224
1 year 150
Extreme 150
224
3 years 139.1
Extreme 139.1
287.8
5 years 139.1
Extreme 139.1
551
10 years 50.13
Extreme 50.13
551
Manager TitleAgeSince
Chief Executive Officer 51 2023-03-27
Chief Tech/Sci/R&D Officer 61 2011-09-07
Investor Relations Contact - -
Director TitleAgeSince
Director/Board Member 65 2015-04-06
Director/Board Member 69 2015-04-06
Director/Board Member 69 2017-09-13
Date Insider Type Main position Quantity % Market Cap.
12/17/25 SellCompany 750,000 0.7706%
2/16/24 Buy

Chief Executive Officer

1,716,739 1.8624%
3/2/22 SellCompany 200,442 0.2174%
Change 5-day change 1-year change 3-year change Capi.($)
-6.45%-12.49%-5.12%-39.90% 19.47B
+0.36%+1.92%-19.95%-12.12% 175B
+0.35%-1.70%-10.73%-7.46% 105B
+0.88%-1.45%+3.44%+58.54% 58.48B
-0.82%-1.93%+38.23%+58.17% 51.36B
+0.01%-4.26%-16.14%-45.31% 42.2B
+1.08%-8.78% - - 31.44B
-1.13%-9.32%-18.19%-44.64% 27.56B
+0.41%+0.20%+59.76%-3.43% 25.32B
+0.04%-4.64%-6.47%-9.17% 20.52B
Average -0.51%-0.18%+2.76%-5.04% 55.64B
Weighted average by Cap. +0.01%+3.58%-4.49%-1.31%

Financials

2026 *2027 *
Net sales 3.17B 3.6B 2.94B 2.7B 5.07B 349B 5.16B 35.16B 13.71B 170B 13.51B 13.22B 590B 3.5B 3.97B 3.25B 2.99B 5.6B 385B 5.7B 38.83B 15.14B 188B 14.92B 14.6B 651B
Net income 380M 432M 353M 325M 609M 41.85B 620M 4.22B 1.65B 20.41B 1.62B 1.59B 70.82B 475M 540M 441M 406M 761M 52.29B 775M 5.28B 2.06B 25.51B 2.03B 1.98B 88.49B
Net Debt 2.34B 2.66B 2.17B 2B 3.75B 258B 3.82B 25.99B 10.14B 126B 9.99B 9.77B 436B 1.77B 2.01B 1.64B 1.51B 2.83B 195B 2.88B 19.64B 7.66B 94.96B 7.55B 7.38B 329B
Logo Sartorius Stedim Biotech
Sartorius Stedim Biotech is a leading provider of cutting-edge equipment and services for the development, quality assurance and production processes of the biopharmaceutical industry. Its integrated solutions covering fermentation, filtration, purification, fluid management and lab technologies are supporting the biopharmaceutical industry around the world to develop and produce drugs safely, timely and economically. For next generation processes, Sartorius Stedim Biotech focuses on single-use technologies and value-added services to meet the rapidly changing technology requirements of the industry it serves. Strongly rooted in the scientific community and closely allied with customers and technology partners, the company is dedicated to its philosophy of turning science into solutions on a daily basis. With its own manufacturing and R&D sites in Europe, North America and Asia and a global network of sales companies, Sartorius Stedim Biotech enjoys a worldwide presence. Its key production sites are located in Germany, France and Puerto Rico.
Employees
10,456
Date Price Change Volume
26-07-23 164.00 -6.45% 215,014
26-07-22 €175.30 +5.22% 134,439
26-07-21 €166.60 -7.55% 213,161
26-07-20 €180.20 -2.96% 55,079
26-07-17 €185.70 -0.91% 107,069
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
175.30EUR
Average target price
232.21EUR
Spread / Average Target
+32.47%

Quarterly revenue - Rate of surprise